Compare
Verses AI Inc. vs Tancheng Group Co., Ltd. vs Real Messenger Corp vs Bioregenx, Inc.
| Latest fiscal year | Verses AI Inc. VRSSF | Tancheng Group Co., Ltd. QSJC | Real Messenger Corp RMSG | Bioregenx, Inc. BRGX |
|---|---|---|---|---|
| Year ended | 2025-03-31 | 2025-12-31 | 2026-03-31 | 2025-12-31 |
| Revenue | $155.0K | $217.0K | $29.5K | $1.85M |
| Revenue growth (YoY) | -92.1% | -56.8% | n/a | -20.8% |
| Gross margin | -307.5% | 25.2% | 51.5% | 81.1% |
| Operating margin | n/m | -171.1% | n/m | -67.1% |
| Net margin | n/m | -171.0% | n/m | -83.2% |
| Net income | -$42.99M | -$371.2K | -$4.09M | -$1.54M |
| EPS (Diluted) | n/a | -$0.08 | -$0.44 | $0.00 |
| Operating cash flow | -$33.09M | -$449.1K | -$3.57M | $39.0K |
| Free cash flow | -$33.12M | n/a | -$3.58M | $29.9K |
| Cash & equivalents | n/a | n/a | $322.0K | n/a |
| Total assets | $6.38M | $1.52M | $995.4K | $411.0K |
| Total liabilities | $15.25M | $3.40M | $508.5K | $4.95M |
| Shareholders' equity | -$8.87M | -$1.88M | $486.8K | -$4.54M |
| Return on year-end equity | n/a | n/a | -840.6% | n/a |
| Shares outstanding | n/a | 4.38M | n/a | 969.02M |
Revenue, most recent five fiscal years
| Fiscal year | Verses AI Inc. | Tancheng Group Co., Ltd. | Real Messenger Corp | Bioregenx, Inc. |
|---|---|---|---|---|
| Latest | $155.0K Ended 2025-03-31 | $217.0K Ended 2025-12-31 | $29.5K Ended 2026-03-31 | $1.85M Ended 2025-12-31 |
| 1 year earlier | $1.97M Ended 2024-03-31 | $502.6K Ended 2024-12-31 | n/a | $2.34M Ended 2024-12-31 |
| 2 years earlier | n/a | $1.97M Ended 2023-12-31 | n/a | $3.41M Ended 2023-12-31 |
| 3 years earlier | n/a | $590.3K Ended 2022-12-31 | n/a | $42.2K Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | n/a | $198.6K Ended 2021-12-31 |